vs
Side-by-side financial comparison of GRAIL, Inc. (GRAL) and HARTE HANKS INC (HHS). Click either name above to swap in a different company.
GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $39.9M, roughly 1.1× HARTE HANKS INC). HARTE HANKS INC runs the higher net margin — 5.5% vs -227.5%, a 233.0% gap on every dollar of revenue. On growth, GRAIL, Inc. posted the faster year-over-year revenue change (14.0% vs -15.4%). HARTE HANKS INC produced more free cash flow last quarter ($-686.0K vs $-63.9M). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs -6.4%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.
GRAL vs HHS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.6M | $39.9M |
| Net Profit | $-99.2M | $2.2M |
| Gross Margin | — | — |
| Operating Margin | -285.4% | -0.3% |
| Net Margin | -227.5% | 5.5% |
| Revenue YoY | 14.0% | -15.4% |
| Net Profit YoY | -2.2% | — |
| EPS (diluted) | $-2.37 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.6M | $39.9M | ||
| Q3 25 | $36.2M | $39.5M | ||
| Q2 25 | $35.5M | $38.6M | ||
| Q1 25 | $31.8M | $41.6M | ||
| Q4 24 | $38.3M | $47.1M | ||
| Q3 24 | $28.7M | $47.6M | ||
| Q2 24 | $32.0M | $45.0M | ||
| Q1 24 | $26.7M | $45.4M |
| Q4 25 | $-99.2M | $2.2M | ||
| Q3 25 | $-89.0M | $-2.3M | ||
| Q2 25 | $-114.0M | $-335.0K | ||
| Q1 25 | $-106.2M | $-392.0K | ||
| Q4 24 | $-97.1M | — | ||
| Q3 24 | $-125.7M | $142.0K | ||
| Q2 24 | $-1.6B | $-27.8M | ||
| Q1 24 | $-218.9M | $-171.0K |
| Q4 25 | -285.4% | -0.3% | ||
| Q3 25 | -346.2% | 1.3% | ||
| Q2 25 | -446.9% | 0.1% | ||
| Q1 25 | -482.5% | -0.1% | ||
| Q4 24 | -358.0% | -3.3% | ||
| Q3 24 | -640.5% | 4.0% | ||
| Q2 24 | -5133.8% | 3.0% | ||
| Q1 24 | -851.1% | 0.8% |
| Q4 25 | -227.5% | 5.5% | ||
| Q3 25 | -245.8% | -5.8% | ||
| Q2 25 | -320.7% | -0.9% | ||
| Q1 25 | -333.6% | -0.9% | ||
| Q4 24 | -253.8% | — | ||
| Q3 24 | -438.7% | 0.3% | ||
| Q2 24 | -4958.8% | -61.8% | ||
| Q1 24 | -819.3% | -0.4% |
| Q4 25 | $-2.37 | $0.30 | ||
| Q3 25 | $-2.46 | $-0.31 | ||
| Q2 25 | $-3.18 | $-0.05 | ||
| Q1 25 | $-3.10 | $-0.05 | ||
| Q4 24 | $-1.49 | $-0.31 | ||
| Q3 24 | $-3.94 | $0.02 | ||
| Q2 24 | $-51.06 | $-3.84 | ||
| Q1 24 | $-7.05 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $249.7M | $5.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.6B | $20.5M |
| Total Assets | $2.9B | $91.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.7M | $5.6M | ||
| Q3 25 | $126.9M | $6.5M | ||
| Q2 25 | $127.4M | $4.8M | ||
| Q1 25 | $133.9M | $9.0M | ||
| Q4 24 | $214.2M | $9.8M | ||
| Q3 24 | $853.6M | $5.9M | ||
| Q2 24 | $958.8M | $11.0M | ||
| Q1 24 | $199.7M | $11.5M |
| Q4 25 | $2.6B | $20.5M | ||
| Q3 25 | $2.2B | $19.9M | ||
| Q2 25 | $2.3B | $22.2M | ||
| Q1 25 | $2.4B | $21.4M | ||
| Q4 24 | $2.5B | $21.7M | ||
| Q3 24 | $2.6B | $21.0M | ||
| Q2 24 | $2.7B | $20.6M | ||
| Q1 24 | — | $20.0M |
| Q4 25 | $2.9B | $91.8M | ||
| Q3 25 | $2.6B | $92.7M | ||
| Q2 25 | $2.7B | $95.0M | ||
| Q1 25 | $2.8B | $100.6M | ||
| Q4 24 | $3.0B | $101.8M | ||
| Q3 24 | $3.1B | $108.1M | ||
| Q2 24 | $3.3B | $109.7M | ||
| Q1 24 | — | $113.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.8M | $737.0K |
| Free Cash FlowOCF − Capex | $-63.9M | $-686.0K |
| FCF MarginFCF / Revenue | -146.5% | -1.7% |
| Capex IntensityCapex / Revenue | 0.2% | 3.6% |
| Cash ConversionOCF / Net Profit | — | 0.33× |
| TTM Free Cash FlowTrailing 4 quarters | $-299.9M | $-4.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.8M | $737.0K | ||
| Q3 25 | $-63.2M | $3.2M | ||
| Q2 25 | $-77.0M | $-4.8M | ||
| Q1 25 | $-95.0M | $-818.0K | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | $-104.6M | $-2.9M | ||
| Q2 24 | $-171.8M | $1.6M | ||
| Q1 24 | $-207.3M | $-5.7M |
| Q4 25 | $-63.9M | $-686.0K | ||
| Q3 25 | $-63.6M | $2.2M | ||
| Q2 25 | $-77.3M | $-5.1M | ||
| Q1 25 | $-95.1M | $-923.0K | ||
| Q4 24 | — | $3.4M | ||
| Q3 24 | $-105.6M | $-4.9M | ||
| Q2 24 | $-173.2M | $926.0K | ||
| Q1 24 | $-209.8M | $-6.2M |
| Q4 25 | -146.5% | -1.7% | ||
| Q3 25 | -175.8% | 5.5% | ||
| Q2 25 | -217.6% | -13.1% | ||
| Q1 25 | -298.6% | -2.2% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | -368.4% | -10.2% | ||
| Q2 24 | -541.7% | 2.1% | ||
| Q1 24 | -785.3% | -13.7% |
| Q4 25 | 0.2% | 3.6% | ||
| Q3 25 | 1.1% | 2.5% | ||
| Q2 25 | 1.0% | 0.6% | ||
| Q1 25 | 0.2% | 0.3% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | 3.4% | 4.0% | ||
| Q2 24 | 4.3% | 1.5% | ||
| Q1 24 | 9.5% | 1.2% |
| Q4 25 | — | 0.33× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -20.76× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
HHS
| Fulfillment And Logistics Services | $17.3M | 43% |
| Customer Care | $13.7M | 34% |
| Other | $8.9M | 22% |
